Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Analysis on the epidemic factors for the Corona Virus Disease].

Identifieur interne : 003275 ( Ncbi/Merge ); précédent : 003274; suivant : 003276

[Analysis on the epidemic factors for the Corona Virus Disease].

Auteurs : H Y Yang [République populaire de Chine] ; G C Duan

Source :

RBID : pubmed:32125129

Abstract

Since December 2019, corona virus disease 2019 (COVID-19) , an emerging infection disease occurred in Wuhan, has spread in the mainland China. The epidemic factors on the basis of knowledge of SARS-CoV-2 were discussed in this paper. This puts a lot of pressure on clinical resources and care. SARS-CoV-2 is a novel corona virus, the onset of COVID-19 is slow, and the pathogenesis of SARS-CoV-2 remains unclear and may lead to multiple organ damage. These put a lot of pressure on clinical resources and care. Source of infection including the patients, asymptomatic carrier and patients in the incubation period are contagious. It is difficult to control source of infection. Routes of SARS-CoV-2 transmission are diversified and the main routes of transmission for COVID-19 are droplet transmission and close contact transmission. All population have susceptibility to SARS-CoV-2. Social factors such population movements and aggregation accelerated the spread of SARS-CoV-2. The Chinese government's adopted measures are positive and effective, and are accepted by the expert group from the World Health Organization. However, it will be a long-term hard work in the future to seriously summarize and think deeply to achieve public health security in China.

DOI: 10.3760/cma.j.cn112150-20200227-00196
PubMed: 32125129

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32125129

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Analysis on the epidemic factors for the Corona Virus Disease].</title>
<author>
<name sortKey="Yang, H Y" sort="Yang, H Y" uniqKey="Yang H" first="H Y" last="Yang">H Y Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001</wicri:regionArea>
<wicri:noRegion>Zhengzhou 450001</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Duan, G C" sort="Duan, G C" uniqKey="Duan G" first="G C" last="Duan">G C Duan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32125129</idno>
<idno type="pmid">32125129</idno>
<idno type="doi">10.3760/cma.j.cn112150-20200227-00196</idno>
<idno type="wicri:Area/PubMed/Corpus">000712</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000712</idno>
<idno type="wicri:Area/PubMed/Curation">000712</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000712</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000037</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000037</idno>
<idno type="wicri:Area/Ncbi/Merge">003275</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Analysis on the epidemic factors for the Corona Virus Disease].</title>
<author>
<name sortKey="Yang, H Y" sort="Yang, H Y" uniqKey="Yang H" first="H Y" last="Yang">H Y Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001</wicri:regionArea>
<wicri:noRegion>Zhengzhou 450001</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Duan, G C" sort="Duan, G C" uniqKey="Duan G" first="G C" last="Duan">G C Duan</name>
</author>
</analytic>
<series>
<title level="j">Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</title>
<idno type="ISSN">0253-9624</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Since December 2019, corona virus disease 2019 (COVID-19) , an emerging infection disease occurred in Wuhan, has spread in the mainland China. The epidemic factors on the basis of knowledge of SARS-CoV-2 were discussed in this paper. This puts a lot of pressure on clinical resources and care. SARS-CoV-2 is a novel corona virus, the onset of COVID-19 is slow, and the pathogenesis of SARS-CoV-2 remains unclear and may lead to multiple organ damage. These put a lot of pressure on clinical resources and care. Source of infection including the patients, asymptomatic carrier and patients in the incubation period are contagious. It is difficult to control source of infection. Routes of SARS-CoV-2 transmission are diversified and the main routes of transmission for COVID-19 are droplet transmission and close contact transmission. All population have susceptibility to SARS-CoV-2. Social factors such population movements and aggregation accelerated the spread of SARS-CoV-2. The Chinese government's adopted measures are positive and effective, and are accepted by the expert group from the World Health Organization. However, it will be a long-term hard work in the future to seriously summarize and think deeply to achieve public health security in China.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32125129</PMID>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0253-9624</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>54</Volume>
<Issue>0</Issue>
<PubDate>
<Year>2020</Year>
<Month>Mar</Month>
<Day>03</Day>
</PubDate>
</JournalIssue>
<Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
<ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
</Journal>
<ArticleTitle>[Analysis on the epidemic factors for the Corona Virus Disease].</ArticleTitle>
<Pagination>
<MedlinePgn>E021</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112150-20200227-00196</ELocationID>
<Abstract>
<AbstractText>Since December 2019, corona virus disease 2019 (COVID-19) , an emerging infection disease occurred in Wuhan, has spread in the mainland China. The epidemic factors on the basis of knowledge of SARS-CoV-2 were discussed in this paper. This puts a lot of pressure on clinical resources and care. SARS-CoV-2 is a novel corona virus, the onset of COVID-19 is slow, and the pathogenesis of SARS-CoV-2 remains unclear and may lead to multiple organ damage. These put a lot of pressure on clinical resources and care. Source of infection including the patients, asymptomatic carrier and patients in the incubation period are contagious. It is difficult to control source of infection. Routes of SARS-CoV-2 transmission are diversified and the main routes of transmission for COVID-19 are droplet transmission and close contact transmission. All population have susceptibility to SARS-CoV-2. Social factors such population movements and aggregation accelerated the spread of SARS-CoV-2. The Chinese government's adopted measures are positive and effective, and are accepted by the expert group from the World Health Organization. However, it will be a long-term hard work in the future to seriously summarize and think deeply to achieve public health security in China.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>H Y</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duan</LastName>
<ForeName>G C</ForeName>
<Initials>GC</Initials>
</Author>
</AuthorList>
<Language>chi</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>03</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
<NlmUniqueID>7904962</NlmUniqueID>
<ISSNLinking>0253-9624</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<OtherAbstract Type="Publisher" Language="chi">
<AbstractText>新型冠状病毒肺炎作为一种新发传染病,自2019年12月初在武汉发生以来,在中国大陆造成广泛流行,其流行过程具有一系列特殊影响因素和条件。本次疫情中,病原体"新",使人产生"疑惑";起病"缓",给临床带来"迷惑";传染源"杂",给防控造成"困惑";传播途径"易",促使发病"剧增";人群易感性"高",引起"高发";加之自然因素"复杂"和社会因素"叠加",是本次疫情广泛传播流行的明显特征。我国采取的积极有效防控策略和措施极大改变了本次疫情的自然流行过程和轨迹,受到世界卫生组织专家组的高度肯定和众多国家和国际组织的赞扬。但认真总结,深入思考,从全局和长远谋划、实现中国乃至全球公共卫生安全将是今后一个相当长期的艰苦工作。.</AbstractText>
</OtherAbstract>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Epidemics</Keyword>
<Keyword MajorTopicYN="N">Risk factors</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32125129</ArticleId>
<ArticleId IdType="doi">10.3760/cma.j.cn112150-20200227-00196</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Duan, G C" sort="Duan, G C" uniqKey="Duan G" first="G C" last="Duan">G C Duan</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Yang, H Y" sort="Yang, H Y" uniqKey="Yang H" first="H Y" last="Yang">H Y Yang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003275 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003275 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:32125129
   |texte=   [Analysis on the epidemic factors for the Corona Virus Disease].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:32125129" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021